Other
John Sapp
Total Trials
6
Recruiting
2
Active
2
Completed
4
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
Failure Rate
0.0%
0 terminated/withdrawn out of 6 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
33%
2 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed trials have results
Key Signals
2 recruiting
Enrollment Performance
Analytics
N/A
2(50.0%)
Phase 4
2(50.0%)
4Total
N/A(2)
Phase 4(2)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (6)
Showing 6 of 6 trials
NCT04162171Not ApplicableRecruiting
Cohort Study - SBRT for VT Radioablation
Role: lead
NCT03713866Not ApplicableRecruiting
Peri-Procedural Transmural Electrophysiological (EP) Imaging of Scar-Related Ventricular Tachycardia
Role: lead
NCT02830360Phase 4Completed
Antiarrhythmics or Ablation for Ventricular Tachycardia 2
Role: lead
NCT02799693Completed
Intramural Needle Ablation for Ventricular Tachycardia
Role: lead
NCT00905853Phase 4Completed
Ventricular Tachycardia (VT) Ablation or Escalated Drug Therapy
Role: lead
NCT01170416Completed
Testing Objective Methods for Template Matching Ventricular Tachycardia and Pacemapping
Role: lead
All 6 trials loaded